A Phase 2 Bridging Study to Assess the New Formulation of ETVAX

Clinical trial NCT05178134 · COMPLETED

Trial details

NCT number: NCT05178134
Sponsor: Scandinavian Biopharma AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healty Volunteers Preventable Disease, Vaccine

Start date: 2021-11-08
Primary completion: 2022-10-20
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.